# A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

> **NCT06537999** · PHASE2 · RECRUITING · sponsor: **Dianthus Therapeutics** · enrollment: 36 (estimated)

## Conditions studied

- Multifocal Motor Neuropathy

## Interventions

- **DRUG:** Claseprubart
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06537999
- **Lead sponsor:** Dianthus Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-17
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06537999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06537999, "A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06537999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*